Securities code: 688277 stock abbreviation: Tinavi Medical Technologies Co.Ltd(688277) Tinavi Medical Technologies Co.Ltd(688277) demonstration and analysis report on stock issuance scheme to specific objects in 2021
December, 2001
Section I necessity of securities issuance and variety selection
In order to meet the capital needs of the company’s business development and enhance the company’s capital strength and profitability, according to the company law and the securities law According to the provisions of relevant laws, administrative regulations, departmental rules or normative documents such as the measures for the administration of securities issuance and registration of companies listed on the science and Innovation Board (for Trial Implementation) (hereinafter referred to as the “measures for the administration of registration”), and the articles of association, Tinavi Medical Technologies Co.Ltd(688277) (hereinafter referred to as the “company”) has prepared a demonstration and analysis report on the scheme of issuing shares to specific objects in 2021.
Unless otherwise specified in this demonstration and analysis report, relevant terms have the same meaning as in the plan for issuing shares to specific objects in Tinavi Medical Technologies Co.Ltd(688277) 2021.
1、 Overview of the use of funds raised by issuing shares to specific objects
The total amount of funds (including issuance expenses) to be raised for this issuance of shares to specific objects shall not exceed 370.2 million yuan (including this amount), and the issuance quantity shall not exceed 15% of the total share capital of the company before this issuance of shares to specific objects, i.e. 62977027 shares. The specific issuance quantity shall be determined by the board of directors of the company and the sponsor of this issuance in accordance with the authorization of the general meeting of shareholders (the lead underwriter) shall negotiate and determine that the total amount of the raised funds will be used for the following items after deducting the issuance expenses:
Unit: 10000 yuan
No. project name total project investment amount of raised funds to be invested
1 new generation orthopedic surgery Siasun Robot&Automation Co.Ltd(300024) R & D and industrialization project 86360.3319520.00
2. Smart medical center construction project 24700.0017500.00
Total 111060.3337020.00
Before the funds raised in this offering are in place, the company will invest with self raised funds according to the actual situation of the investment projects with raised funds, and replace them in accordance with the procedures specified in relevant laws and regulations after the raised funds are in place. After the raised funds are in place, if the net amount of the actual raised funds after deducting the issuance expenses is less than the total amount of the proposed raised funds, within the scope of the investment projects of the raised funds in this issuance, the company will adjust and determine the specific investment projects, priorities and specific investment amounts of the raised funds according to the actual amount of the raised funds and the priorities of the projects, The insufficient funds raised will be raised by the company itself.
2、 The necessity of this issuance of securities and its variety selection
(i) Background of this issuance of shares to specific objects
1. China’s orthopaedic surgery market is in great demand, and the pain points of traditional orthopaedic surgery need to be solved urgently
With the development of social modernization, the wide application of modern transportation tools and the intensification of the global aging trend, the incidence rate of spinal diseases, joint injuries and Department of orthopedics trauma has increased year by year. China has a large population base and a large number of patients. Orthopedic diseases have become a common and frequently occurring disease in modern society. Among them, orthopedic diseases caused by trauma belong to acute diseases, which need to be treated quickly on site. Due to the uneven medical resources, grass-roots medical institutions are often unable to implement complex orthopedic operations, and it is difficult to seek medical treatment in different places, resulting in the failure of patients to receive timely treatment. For chronic diseases such as spine and joints, with the improvement of Chinese people’s quality of life and the pursuit of higher treatment effect, patients have greater demand for efficient and safe orthopedic surgery. Therefore, it is urgent to introduce Siasun Robot&Automation Co.Ltd(300024) auxiliary technology to provide more satisfactory treatment schemes for patients.
For orthopaedic diseases, surgery is the main treatment method, while Chinese Orthopaedic Surgery mostly adopts the traditional “unarmed operation” mode, which has the pain points of “complex structure, deep location, great trauma and difficult judgment”, and the operation risk is high; The effect of surgery depends heavily on the experience of doctors. However, due to the long learning curve and the small number of surgeons with rich clinical experience, it can not meet the market demand; Orthopedic doctors suffer from radiation damage in traditional orthopedic surgery, and the risk of cancer is high.
2. Precision medicine and intelligent medicine are the future direction of orthopaedic surgery. Modern orthopaedic surgery urgently needs to introduce orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024)
With the rapid development of minimally invasive surgery and intelligent surgery, the concepts of intelligent medicine and precision medicine are gradually rising. Orthopaedic surgery navigation and positioning Siasun Robot&Automation Co.Ltd(300024) technology represents the future direction of orthopaedic precision treatment. With the proposal of made in China 2025 and medical equipment industry development plan (2021-2025), the high-end medical equipment manufacturing industry is gradually booming. In the medical field, orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) Become the industry representative, take the lead in realizing technological breakthrough, successfully apply it to many bone surgery, and play an important role in trauma, spinal trauma and other operations. At the same time, the relatively small number of experienced orthopaedic surgeons also directly leads to the increase in the demand for orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) . Orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) can assist doctors in diagnosis and treatment decisions, greatly reducing the burden of doctors and the pain of patients.
Limited by the technical level, manufacturing level and channel monopoly of international medical giants, China’s medical Siasun Robot&Automation Co.Ltd(300024) industry has been in the follow-up stage. With the emergence of “Tianji” orthopedic surgery navigation positioning Siasun Robot&Automation Co.Ltd(300024) , the technical advantage of “international original” has gradually become prominent, which has been combined with high-speed rail, C919 aircraft Shenwei Taihu Zhiguang supercomputer and other high-end equipment are among the heavy weapons of large countries. As strategic equipment with medical attributes, its market demand continues to rise. With the continuous expansion of orthopaedic surgery applications and the continuous improvement of residents’ living standards, orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) will face more, more complex and more demanding surgical application scenarios. The market puts forward higher requirements for orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) in terms of performance and supply. Therefore, with more and more surgical application scenarios emerging, the market demand for orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) continues to grow, and the orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) industry will usher in a new leap.
In addition, in the face of the expansion of the application scenarios of orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) and the continuous increase of the volume of Orthopaedic Surgery, orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) plays more functions and roles in orthopaedic surgery. Orthopaedic surgery navigation and positioning Siasun Robot&Automation Co.Ltd(300024) can realize more personalized operation scheme design and accurate positioning, so as to effectively reduce the dependence of surgery on doctors’ experience and skills and improve the quality of surgery, Shorten the postoperative rehabilitation cycle, reduce the medical cost as a whole, and promote the application and promotion of advanced clinical concepts such as minimally invasive and intelligent. At present, there are few orthopaedic surgical navigation and positioning Siasun Robot&Automation Co.Ltd(300024) applied in China. However, with the deepening of doctors’ understanding of the function, scope of application, clinical accuracy and surgical effect of surgical Siasun Robot&Automation Co.Ltd(300024) products, orthopaedic doctors’ acceptance of Siasun Robot&Automation Co.Ltd(300024) intelligent assisted surgery is gradually improving, and orthopaedic manual navigation and positioning Siasun Robot&Automation Co.Ltd(300024) is in the stage of application and promotion, The market demand for orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) is growing.
The company’s orthopaedic surgery navigation positioning Siasun Robot&Automation Co.Ltd(300024) promotes the minimally invasive, standardized and intelligent clinical treatment methods, helps to solve the pain points of traditional orthopaedic surgery and realize the short-range learning curve of orthopaedic doctors. At the same time, the company cooperates to create a National Orthopaedic Surgery Siasun Robot&Automation Co.Ltd(300024) application center, promotes the equalization of medical resources and participates in the formulation of international and national standards, Help doctors create new international methods.
3. The construction of the project complies with relevant national and local plans and industrial policies (1) meets the requirements of medical equipment industry development plan (2021-2025) (Exposure Draft)
In order to accelerate the high-quality development of the medical equipment industry, The Ministry of industry and information technology issued the medical equipment industry development plan (2021-2025) (Draft for comments) (hereinafter referred to as “draft for comments”) in February 2021 and solicited comments from the public. In March 2021, the medical equipment industry development plan (2021-2025) passed the expert demonstration.
The exposure draft points out that there is a huge market space for the development of medical equipment. The medical and health service modes such as telemedicine, mobile medicine, smart medicine and precision medicine are booming. The industrial ecology is undergoing profound changes and the competitive pattern is being reshaped at an accelerated pace. China’s medical equipment industry is facing a rare “window” for technological catch-up and upgrading. The exposure draft also proposes to tackle key problems in intelligent surgery Siasun Robot&Automation Co.Ltd(300024) , improve the intelligent control functions such as visual real-time navigation and force sensing follow-up in the treatment process, promote the standardized application of surgery Siasun Robot&Automation Co.Ltd(300024) in the treatment of major diseases, and improve the performance and quality of endoscopic surgery Siasun Robot&Automation Co.Ltd(300024) , orthopedic surgery Siasun Robot&Automation Co.Ltd(300024) , neurosurgery Siasun Robot&Automation Co.Ltd(300024) and other equipment.
In the action of integrated development of medical equipment, focus on supporting and promoting the embedding of new technologies such as artificial intelligence, 5g, big data and cloud computing into medical equipment; Promote the development of remote surgery and other series of medical Siasun Robot&Automation Co.Ltd(300024) , and promote the development of smart hospitals; Promote “5g + medical health”, promote the application of 5g in medical health such as remote consultation, remote surgery, medical assistance and remote follow-up of chronic diseases, and promote the sinking of high-end medical resources to serve the grass-roots level.
In the construction of high-end medical equipment application demonstration base, build high-end medical equipment industry cluster, support the cooperation between medical institutions, production enterprises, scientific research institutes and financial institutions, and increase the support for R & D, production, clinical verification, promotion and application of mainstream medical equipment products with large clinical demand and heavy medical burden and key products for grass-roots hierarchical diagnosis and treatment, Promote the development of characteristic medical equipment industry clusters.
In terms of safeguard measures, it puts forward innovative support modes and promotes the promotion and application, encourages qualified places to carry out the construction of medical equipment application and promotion centers, medical insurance payment and charge pricing of new products, and actively explore the modes of Innovation Medical Management Co.Ltd(002173) equipment products such as “purchase technical services” and “financial leasing services”; It is proposed that the departments of industry and information technology, development and reform, science and technology, finance, health care, housing and construction, state-owned assets, market supervision, medical insurance and drug supervision should focus on the planning objectives and tasks, formulate supporting policies and measures according to the division of functions, and strengthen organizational coordination.
In terms of investment projects raised by the company, the new generation orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) R & D and industrialization project will increase the technical upgrading, performance and function improvement of domestic orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) , promote the expansion of surgical Siasun Robot&Automation Co.Ltd(300024) indications, meet the requirements of “coordinated development of medicine and industry”, and belong to the key areas supported by the exposure draft; Focusing on the integration goal of “5g + medical health”, the company’s smart medical center construction project integrates big data and “cloud tube end” technology to promote the application of 5g in remote surgery, which is in line with the spirit of medical equipment integration development action, helps to promote the sinking of high-end medical resources and hierarchical diagnosis and treatment, and helps to build a medical equipment industry cluster. (2) It meets the requirements of the proposal of the CPC Central Committee on formulating the 14th five year plan for national economic and social development and the long-term objectives for 2005
The proposal of the CPC Central Committee on formulating the 14th five year plan for national economic and social development and the long-term objectives for 2005, which was considered and adopted at the Fifth Plenary Session of the 19th Central Committee of China in October 2020, put forward that, “Adhere to the core position of innovation in the overall situation of China’s modernization, take scientific and technological self-reliance and self-improvement as the strategic support for national development, and face the world’s scientific and technological frontier, the main economic battlefield, the major national needs and the people’s life and health”; “Adhere to the public welfare nature of basic medical and health undertakings, deepen the reform of the medical and health system, accelerate the expansion of high-quality medical resources and balanced regional distribution, accelerate the construction of a hierarchical diagnosis and treatment system, strengthen the construction and management assessment of public hospitals, promote the reform of the state’s organization of centralized procurement and use of drugs and consumables, and develop high-end medical equipment. Support social medical management and promote telemedicine” “Aiming at the frontier fields of artificial intelligence, quantum information, integrated circuits, life and health, brain science, biological breeding, aerospace science and technology, deep earth and deep sea, we will implement a number of forward-looking and strategic national major science and technology projects. We will formulate and implement strategic science plans and scientific projects, and promote the optimal allocation of scientific research forces and resource sharing of scientific research institutes, universities and enterprises.”. The company always takes scientific and technological innovation as the soul and creates original research products “facing the world’s scientific and technological frontier, the main economic battlefield, the major national needs and people’s life and health”. Its main product orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) is high-end medical equipment. The implementation of this fund-raising project will accelerate the research and development of a new generation of orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) and better serve the medical industry. At the same time, the orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) produced can be installed in hospitals at all levels, effectively shorten the learning curve of young doctors, and is conducive to accelerating the construction of hierarchical diagnosis and treatment system and reducing medical pressure. Therefore, the construction of the company’s fund-raising projects meets the requirements of the proposal of the CPC Central Committee on formulating the 14th five year plan and the long-term objectives for 2005 for national economic and social development. (3) Comply with the Guiding Catalogue for industrial structure adjustment (2019 version)
Guiding Catalogue for industrial structure adjustment (2019 version) (hereinafter referred to as the catalogue) ）It is an important basis for guiding investment direction, government management of investment projects, formulation and implementation of fiscal, tax, credit, land, import and export policies. It is composed of three categories of directories: encouragement, restriction and elimination. Those that do not belong to the above three categories and comply with relevant national laws, regulations and policies are allowed. Among them, the encouraged category mainly refers to the key technologies, equipment and products that play an important role in promoting economic and social development, are conducive to resource conservation, environmental protection, optimization and upgrading of industrial structure, and need to be encouraged and supported by policies and measures. The 13th item of encouraged medicine in the catalogue points out: “development and application of artificial intelligence auxiliary medical equipment, high-end radiotherapy equipment, endoscope, surgery Siasun Robot&Automation Co.Ltd(300024) and other high-end surgical equipment, stent, prosthesis and other new implant intervention equipment and materials, and additive manufacturing technology.” The company’s fund-raising project is committed to the R & D, production and sales promotion of orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) , helps promote the intelligent upgrading of orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) , and promotes the market application of orthopaedic surgery Siasun Robot&Automation Co.Ltd(300024) . It is a development industry encouraged by the state. (4) Meet the requirements of the guidelines for pharmaceutical industry development planning
The pharmaceutical industry is an important industry related to the national economy and the people’s livelihood, an important guarantee for promoting the construction of a healthy China, and a key period for the overall leap of the pharmaceutical industry. In order to accelerate the transformation of the pharmaceutical industry from large to strong, six ministries and commissions, including the Ministry of industry and information technology, the national development and Reform Commission, the Ministry of science and technology, the Ministry of Commerce, the health and Family Planning Commission and the State Food and drug administration, issued the Planning Guide for the development of the pharmaceutical industry (hereinafter referred to as the “planning guide”) in November 2016. The planning guide puts forward “key development” in “promoting the development of key areas”
